Mei-Sing Ong, PhD; Kenneth D. Mandl, MD, MPH
Disclaimer: The funding bodies played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. All authors made substantial contributions to the conception, design and interpretation of data, and writing of the manuscript and gave final approval of the version to be published. Dr. Ong had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Grant Support: By Aetna. Dr. Ong is supported by a grant from the National Health and Medical Research Council, Australia (APP1052871), and the National Institutes of Health (T15LM007092).
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L16-0422.
Ong M, Mandl KD. Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2017;166:451–452. doi: https://doi.org/10.7326/L16-0422
Download citation file:
Published: Ann Intern Med. 2017;166(6):451-452.
Cancer Screening/Prevention, Hematology/Oncology, Prevention/Screening, Prostate Cancer.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use